PRUCROS 40MG TAB

About

Prucalopride is a highly selective, high-affinity serotonin (5-HT4) receptor agonist specifically developed for the symptomatic treatment of chronic idiopathic constipation in adults for whom laxatives have failed to provide adequate relief. Its primary mode of action involves stimulating the 5-HT4 receptors located on enteric neurons within the gastrointestinal tract. This stimulation enhances the release of acetylcholine and other neurotransmitters, which in turn promotes propulsive colonic motility and accelerates overall gastrointestinal transit. By restoring more regular and effective bowel movements, prucalopride helps to alleviate the discomfort and infrequent defecation associated with chronic constipation. Its selectivity for the 5-HT4 receptor minimizes off-target effects, contributing to a generally favorable tolerability profile compared to older, less selective prokinetic agents. It represents an important therapeutic option for patients struggling with persistent constipation.

Uses

• Treatment of chronic idiopathic constipation.
• Relief of symptoms associated with chronic constipation.
• Improvement of bowel movement frequency.
• Enhancement of colonic transit in adults.

Directions For Use

Take one tablet orally once daily, with or without food.

Benefits

• Effective for chronic idiopathic constipation.
• Improves bowel movement frequency.
• Enhances colonic transit.
• Selective 5-HT4 receptor agonist.
• Generally well-tolerated.
• Can improve quality of life.

Side Effects

• Headache
• Nausea
• Diarrhea
• Abdominal pain
• Fatigue
• Dizziness
• Flatulence
• Vomiting
• Dyspepsia
• Anorexia
• Palpitations
• Urinary tract infection

Safety Measures

• Alcohol - No specific interaction with alcohol is known, but excessive alcohol may worsen gastrointestinal symptoms.
• Pregnancy - Not recommended during pregnancy due to insufficient data; use only if potential benefits justify the potential risks to the fetus.
• Breastfeeding - Prucalopride is excreted in breast milk; breastfeeding is not recommended due to potential effects on the infant.
• Liver - No dose adjustment is typically needed for mild to moderate hepatic impairment; use with caution in severe impairment.
• Kidney - Dose adjustment is required for patients with severe renal impairment (creatinine clearance <30 mL/min).
• Lung - No specific safety concerns or dose adjustments related to lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.